APO Research
Talk to an analyst

APO RESEARCH · REPORT

Morquio Syndrome Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Morquio Syndrome Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025197 pages

Choose your research edition.

Industry ResearchMorquio Syndrome Treatment Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Morquio Syndrome Treatment Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Morquio Syndrome Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Morquio Syndrome Treatment Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Morquio Syndrome Treatment Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Morquio Syndrome Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Morquio Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Morquio Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Morquio Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Morquio Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Morquio Syndrome Treatment include Sanofi, Roche, Pfizer, Bayer, Shire, Sangamo Therapeutics, Lupin, JCR Pharmaceuticals and Green Cross, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Morquio Syndrome Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Morquio Syndrome Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Morquio Syndrome Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Morquio Syndrome Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Morquio Syndrome Treatment Segment by Company

Sanofi

Roche

Pfizer

Bayer

Shire

Sangamo Therapeutics

Lupin

JCR Pharmaceuticals

Green Cross

Genzyme Corporation,

Daiichi Sankyo

Concert Pharmaceuticals

Cipla

Cambrex Corporation

BioMarin

Alexion Pharmaceuticals

Morquio Syndrome Treatment Segment by Type

Morquio A

Morquio B

Morquio Syndrome Treatment Segment by Application

Hospital

Clinic

Others

Morquio Syndrome Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Morquio Syndrome Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Morquio Syndrome Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Morquio Syndrome Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Morquio Syndrome Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Morquio Syndrome Treatment industry.

Chapter 3: Detailed analysis of Morquio Syndrome Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Morquio Syndrome Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Morquio Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Morquio A Table 3. Key Players of Morquio B Table 4. Global Morquio Syndrome Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Others Table 8. Global Morquio Syndrome Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Morquio Syndrome Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Morquio Syndrome Treatment Market Share by Region (2021-2026) Table 11. Global Morquio Syndrome Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Morquio Syndrome Treatment Market Share by Region (2027-2032) Table 13. Morquio Syndrome Treatment Industry Trends Table 14. Morquio Syndrome Treatment Industry Drivers Table 15. Morquio Syndrome Treatment Industry Opportunities and Challenges Table 16. Morquio Syndrome Treatment Industry Restraints Table 17. Global Morquio Syndrome Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Morquio Syndrome Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Morquio Syndrome Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Morquio Syndrome Treatment Key Company Head Office and Area Served Table 21. Global Morquio Syndrome Treatment Company, Product Type & Application Table 22. Global Morquio Syndrome Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Morquio Syndrome Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Morquio Syndrome Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Morquio Syndrome Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Morquio Syndrome Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Morquio Syndrome Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Morquio Syndrome Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Morquio Syndrome Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Morquio Syndrome Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Morquio Syndrome Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Morquio Syndrome Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Morquio Syndrome Treatment Revenue Market Share by Application (2027-2032) Table 35. Sanofi Company Information Table 36. Sanofi Business Overview Table 37. Sanofi Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Sanofi Morquio Syndrome Treatment Product Portfolio Table 39. Sanofi Recent Development Table 40. Roche Company Information Table 41. Roche Business Overview Table 42. Roche Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Roche Morquio Syndrome Treatment Product Portfolio Table 44. Roche Recent Development Table 45. Pfizer Company Information Table 46. Pfizer Business Overview Table 47. Pfizer Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Pfizer Morquio Syndrome Treatment Product Portfolio Table 49. Pfizer Recent Development Table 50. Bayer Company Information Table 51. Bayer Business Overview Table 52. Bayer Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Bayer Morquio Syndrome Treatment Product Portfolio Table 54. Bayer Recent Development Table 55. Shire Company Information Table 56. Shire Business Overview Table 57. Shire Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Shire Morquio Syndrome Treatment Product Portfolio Table 59. Shire Recent Development Table 60. Sangamo Therapeutics Company Information Table 61. Sangamo Therapeutics Business Overview Table 62. Sangamo Therapeutics Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Sangamo Therapeutics Morquio Syndrome Treatment Product Portfolio Table 64. Sangamo Therapeutics Recent Development Table 65. Lupin Company Information Table 66. Lupin Business Overview Table 67. Lupin Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Lupin Morquio Syndrome Treatment Product Portfolio Table 69. Lupin Recent Development Table 70. JCR Pharmaceuticals Company Information Table 71. JCR Pharmaceuticals Business Overview Table 72. JCR Pharmaceuticals Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. JCR Pharmaceuticals Morquio Syndrome Treatment Product Portfolio Table 74. JCR Pharmaceuticals Recent Development Table 75. Green Cross Company Information Table 76. Green Cross Business Overview Table 77. Green Cross Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Green Cross Morquio Syndrome Treatment Product Portfolio Table 79. Green Cross Recent Development Table 80. Genzyme Corporation, Company Information Table 81. Genzyme Corporation, Business Overview Table 82. Genzyme Corporation, Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Genzyme Corporation, Morquio Syndrome Treatment Product Portfolio Table 84. Genzyme Corporation, Recent Development Table 85. Daiichi Sankyo Company Information Table 86. Daiichi Sankyo Business Overview Table 87. Daiichi Sankyo Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Daiichi Sankyo Morquio Syndrome Treatment Product Portfolio Table 89. Daiichi Sankyo Recent Development Table 90. Concert Pharmaceuticals Company Information Table 91. Concert Pharmaceuticals Business Overview Table 92. Concert Pharmaceuticals Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Concert Pharmaceuticals Morquio Syndrome Treatment Product Portfolio Table 94. Concert Pharmaceuticals Recent Development Table 95. Cipla Company Information Table 96. Cipla Business Overview Table 97. Cipla Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Cipla Morquio Syndrome Treatment Product Portfolio Table 99. Cipla Recent Development Table 100. Cambrex Corporation Company Information Table 101. Cambrex Corporation Business Overview Table 102. Cambrex Corporation Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Cambrex Corporation Morquio Syndrome Treatment Product Portfolio Table 104. Cambrex Corporation Recent Development Table 105. BioMarin Company Information Table 106. BioMarin Business Overview Table 107. BioMarin Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. BioMarin Morquio Syndrome Treatment Product Portfolio Table 109. BioMarin Recent Development Table 110. Alexion Pharmaceuticals Company Information Table 111. Alexion Pharmaceuticals Business Overview Table 112. Alexion Pharmaceuticals Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Alexion Pharmaceuticals Morquio Syndrome Treatment Product Portfolio Table 114. Alexion Pharmaceuticals Recent Development Table 115. North America Morquio Syndrome Treatment Market Size by Type (2021-2026) & (US$ Million) Table 116. North America Morquio Syndrome Treatment Market Size by Type (2027-2032) & (US$ Million) Table 117. North America Morquio Syndrome Treatment Market Size by Application (2021-2026) & (US$ Million) Table 118. North America Morquio Syndrome Treatment Market Size by Application (2027-2032) & (US$ Million) Table 119. North America Morquio Syndrome Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Morquio Syndrome Treatment Market Size by Country (2021-2026) Table 121. North America Morquio Syndrome Treatment Market Size by Country (2027-2032) Table 122. Europe Morquio Syndrome Treatment Market Size by Type (2021-2026) & (US$ Million) Table 123. Europe Morquio Syndrome Treatment Market Size by Type (2027-2032) & (US$ Million) Table 124. Europe Morquio Syndrome Treatment Market Size by Application (2021-2026) & (US$ Million) Table 125. Europe Morquio Syndrome Treatment Market Size by Application (2027-2032) & (US$ Million) Table 126. Europe Morquio Syndrome Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Morquio Syndrome Treatment Market Size by Country (2021-2026) Table 128. Europe Morquio Syndrome Treatment Market Size by Country (2027-2032) Table 129. China Morquio Syndrome Treatment Market Size by Type (2021-2026) & (US$ Million) Table 130. China Morquio Syndrome Treatment Market Size by Type (2027-2032) & (US$ Million) Table 131. China Morquio Syndrome Treatment Market Size by Application (2021-2026) & (US$ Million) Table 132. China Morquio Syndrome Treatment Market Size by Application (2027-2032) & (US$ Million) Table 133. Asia Morquio Syndrome Treatment Market Size by Type (2021-2026) & (US$ Million) Table 134. Asia Morquio Syndrome Treatment Market Size by Type (2027-2032) & (US$ Million) Table 135. Asia Morquio Syndrome Treatment Market Size by Application (2021-2026) & (US$ Million) Table 136. Asia Morquio Syndrome Treatment Market Size by Application (2027-2032) & (US$ Million) Table 137. Asia Morquio Syndrome Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Asia Morquio Syndrome Treatment Market Size by Country (2021-2026) Table 139. Asia Morquio Syndrome Treatment Market Size by Country (2027-2032) Table 140. South America, Middle East & Africa Morquio Syndrome Treatment Market Size by Type (2021-2026) & (US$ Million) Table 141. South America, Middle East & Africa Morquio Syndrome Treatment Market Size by Type (2027-2032) & (US$ Million) Table 142. South America, Middle East & Africa Morquio Syndrome Treatment Market Size by Application (2021-2026) & (US$ Million) Table 143. South America, Middle East & Africa Morquio Syndrome Treatment Market Size by Application (2027-2032) & (US$ Million) Table 144. South America, Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. South America, Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2021-2026) Table 146. South America, Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2027-2032) Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Morquio Syndrome Treatment Product Image Figure 2. Global Morquio Syndrome Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Morquio Syndrome Treatment Market Share by Type: 2025 VS 2032 Figure 4. Morquio A Image Figure 5. Morquio B Image Figure 6. Global Morquio Syndrome Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Morquio Syndrome Treatment Market Share by Application: 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Morquio Syndrome Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 13. Global Morquio Syndrome Treatment Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Morquio Syndrome Treatment Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Morquio Syndrome Treatment Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Morquio Syndrome Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Morquio Syndrome Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global Morquio Syndrome Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Morquio Syndrome Treatment Revenue Market Share by Application (2021-2032) Figure 22. North America Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 23. North America Morquio Syndrome Treatment Market Share by Type (2021-2032) Figure 24. North America Morquio Syndrome Treatment Market Share by Application (2021-2032) Figure 25. North America Morquio Syndrome Treatment Market Share by Country (2021-2032) Figure 26. United States Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 27. Canada Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Europe Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe Morquio Syndrome Treatment Market Share by Type (2021-2032) Figure 31. Europe Morquio Syndrome Treatment Market Share by Application (2021-2032) Figure 32. Europe Morquio Syndrome Treatment Market Share by Country (2021-2032) Figure 33. Germany Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 34. France Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 36. Italy Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Russia Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 39. China Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China Morquio Syndrome Treatment Market Share by Type (2021-2032) Figure 41. China Morquio Syndrome Treatment Market Share by Application (2021-2032) Figure 42. Asia Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 43. Asia Morquio Syndrome Treatment Market Share by Type (2021-2032) Figure 44. Asia Morquio Syndrome Treatment Market Share by Application (2021-2032) Figure 45. Asia Morquio Syndrome Treatment Market Share by Country (2021-2032) Figure 46. Japan Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 50. India Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Australia Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Morquio Syndrome Treatment Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Morquio Syndrome Treatment Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Morquio Syndrome Treatment Market Share by Country (2021-2032) Figure 56. Brazil Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 61. UAE Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Chile Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Morquio A
  • Morquio B
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sanofi
  • Roche
  • Pfizer
  • Bayer
  • Shire
  • Sangamo Therapeutics
  • Lupin
  • JCR Pharmaceuticals
  • Green Cross
  • Genzyme Corporation,
  • Daiichi Sankyo
  • Concert Pharmaceuticals
  • Cipla
  • Cambrex Corporation
  • BioMarin
  • Alexion Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Morquio Syndrome Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Morquio A
  5. 1.2.3 Morquio B
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Morquio Syndrome Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Morquio Syndrome Treatment Growth Trends by Region
  13. 1.5.1 Global Morquio Syndrome Treatment Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Morquio Syndrome Treatment Market Size by Region (2021-2026)
  15. 1.5.3 Morquio Syndrome Treatment Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Morquio Syndrome Treatment Market Dynamics
  1. 2.1 Morquio Syndrome Treatment Industry Trends
  2. 2.2 Morquio Syndrome Treatment Industry Drivers
  3. 2.3 Morquio Syndrome Treatment Industry Opportunities and Challenges
  4. 2.4 Morquio Syndrome Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Morquio Syndrome Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Morquio Syndrome Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Morquio Syndrome Treatment Key Company Head office and Area Served
  4. 3.4 Global Morquio Syndrome Treatment Company, Product Type & Application
  5. 3.5 Global Morquio Syndrome Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Morquio Syndrome Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Morquio Syndrome Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Morquio Syndrome Treatment Tier 1, Tier 2, and Tier 3
4 Morquio Syndrome Treatment Market by Type
  1. 4.1 Global Morquio Syndrome Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Morquio Syndrome Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Morquio Syndrome Treatment Market Size Share by Type (2021-2032)
5 Morquio Syndrome Treatment Market by Application
  1. 5.1 Global Morquio Syndrome Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Morquio Syndrome Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Morquio Syndrome Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sanofi Morquio Syndrome Treatment Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Roche Morquio Syndrome Treatment Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Pfizer Morquio Syndrome Treatment Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Bayer Morquio Syndrome Treatment Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 Shire
  26. 6.5.1 Shire Company Information
  27. 6.5.2 Shire Business Overview
  28. 6.5.3 Shire Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Shire Morquio Syndrome Treatment Product Portfolio
  30. 6.5.5 Shire Recent Developments
  31. 6.6 Sangamo Therapeutics
  32. 6.6.1 Sangamo Therapeutics Company Information
  33. 6.6.2 Sangamo Therapeutics Business Overview
  34. 6.6.3 Sangamo Therapeutics Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Sangamo Therapeutics Morquio Syndrome Treatment Product Portfolio
  36. 6.6.5 Sangamo Therapeutics Recent Developments
  37. 6.7 Lupin
  38. 6.7.1 Lupin Company Information
  39. 6.7.2 Lupin Business Overview
  40. 6.7.3 Lupin Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Lupin Morquio Syndrome Treatment Product Portfolio
  42. 6.7.5 Lupin Recent Developments
  43. 6.8 JCR Pharmaceuticals
  44. 6.8.1 JCR Pharmaceuticals Company Information
  45. 6.8.2 JCR Pharmaceuticals Business Overview
  46. 6.8.3 JCR Pharmaceuticals Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 JCR Pharmaceuticals Morquio Syndrome Treatment Product Portfolio
  48. 6.8.5 JCR Pharmaceuticals Recent Developments
  49. 6.9 Green Cross
  50. 6.9.1 Green Cross Company Information
  51. 6.9.2 Green Cross Business Overview
  52. 6.9.3 Green Cross Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Green Cross Morquio Syndrome Treatment Product Portfolio
  54. 6.9.5 Green Cross Recent Developments
  55. 6.10 Genzyme Corporation,
  56. 6.10.1 Genzyme Corporation, Company Information
  57. 6.10.2 Genzyme Corporation, Business Overview
  58. 6.10.3 Genzyme Corporation, Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Genzyme Corporation, Morquio Syndrome Treatment Product Portfolio
  60. 6.10.5 Genzyme Corporation, Recent Developments
  61. 6.11 Daiichi Sankyo
  62. 6.11.1 Daiichi Sankyo Company Information
  63. 6.11.2 Daiichi Sankyo Business Overview
  64. 6.11.3 Daiichi Sankyo Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Daiichi Sankyo Morquio Syndrome Treatment Product Portfolio
  66. 6.11.5 Daiichi Sankyo Recent Developments
  67. 6.12 Concert Pharmaceuticals
  68. 6.12.1 Concert Pharmaceuticals Company Information
  69. 6.12.2 Concert Pharmaceuticals Business Overview
  70. 6.12.3 Concert Pharmaceuticals Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Concert Pharmaceuticals Morquio Syndrome Treatment Product Portfolio
  72. 6.12.5 Concert Pharmaceuticals Recent Developments
  73. 6.13 Cipla
  74. 6.13.1 Cipla Company Information
  75. 6.13.2 Cipla Business Overview
  76. 6.13.3 Cipla Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Cipla Morquio Syndrome Treatment Product Portfolio
  78. 6.13.5 Cipla Recent Developments
  79. 6.14 Cambrex Corporation
  80. 6.14.1 Cambrex Corporation Company Information
  81. 6.14.2 Cambrex Corporation Business Overview
  82. 6.14.3 Cambrex Corporation Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Cambrex Corporation Morquio Syndrome Treatment Product Portfolio
  84. 6.14.5 Cambrex Corporation Recent Developments
  85. 6.15 BioMarin
  86. 6.15.1 BioMarin Company Information
  87. 6.15.2 BioMarin Business Overview
  88. 6.15.3 BioMarin Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 BioMarin Morquio Syndrome Treatment Product Portfolio
  90. 6.15.5 BioMarin Recent Developments
  91. 6.16 Alexion Pharmaceuticals
  92. 6.16.1 Alexion Pharmaceuticals Company Information
  93. 6.16.2 Alexion Pharmaceuticals Business Overview
  94. 6.16.3 Alexion Pharmaceuticals Morquio Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Alexion Pharmaceuticals Morquio Syndrome Treatment Product Portfolio
  96. 6.16.5 Alexion Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Morquio Syndrome Treatment Market Size (2021-2032)
  2. 7.2 North America Morquio Syndrome Treatment Market Size by Type
  3. 7.2.1 North America Morquio Syndrome Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Morquio Syndrome Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Morquio Syndrome Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Morquio Syndrome Treatment Market Size by Application
  7. 7.3.1 North America Morquio Syndrome Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Morquio Syndrome Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Morquio Syndrome Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Morquio Syndrome Treatment Market Size by Country
  11. 7.4.1 North America Morquio Syndrome Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Morquio Syndrome Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Morquio Syndrome Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Morquio Syndrome Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Morquio Syndrome Treatment Market Size (2021-2032)
  2. 8.2 Europe Morquio Syndrome Treatment Market Size by Type
  3. 8.2.1 Europe Morquio Syndrome Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Morquio Syndrome Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Morquio Syndrome Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Morquio Syndrome Treatment Market Size by Application
  7. 8.3.1 Europe Morquio Syndrome Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Morquio Syndrome Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Morquio Syndrome Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Morquio Syndrome Treatment Market Size by Country
  11. 8.4.1 Europe Morquio Syndrome Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Morquio Syndrome Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Morquio Syndrome Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Morquio Syndrome Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Morquio Syndrome Treatment Market Size (2021-2032)
  2. 9.2 China Morquio Syndrome Treatment Market Size by Type
  3. 9.2.1 China Morquio Syndrome Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Morquio Syndrome Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Morquio Syndrome Treatment Market Share by Type (2021-2032)
  6. 9.3 China Morquio Syndrome Treatment Market Size by Application
  7. 9.3.1 China Morquio Syndrome Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Morquio Syndrome Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Morquio Syndrome Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Morquio Syndrome Treatment Market Size (2021-2032)
  2. 10.2 Asia Morquio Syndrome Treatment Market Size by Type
  3. 10.2.1 Asia Morquio Syndrome Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Morquio Syndrome Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Morquio Syndrome Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Morquio Syndrome Treatment Market Size by Application
  7. 10.3.1 Asia Morquio Syndrome Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Morquio Syndrome Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Morquio Syndrome Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Morquio Syndrome Treatment Market Size by Country
  11. 10.4.1 Asia Morquio Syndrome Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Morquio Syndrome Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Morquio Syndrome Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Morquio Syndrome Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Morquio Syndrome Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Morquio Syndrome Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Morquio Syndrome Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Morquio Syndrome Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Morquio Syndrome Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Morquio Syndrome Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Morquio Syndrome Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Morquio Syndrome Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Morquio Syndrome Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Morquio Syndrome Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Morquio Syndrome Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst